Surgical Innovations Group Plc

0.00 (0.0%)
Share Name Share Symbol Market Type Share ISIN Share Description
Surgical Innovations Group Plc LSE:SUN London Ordinary Share GB0004016704 ORD 1P
  Price Change % Change Share Price Shares Traded Last Trade
  0.00 0.0% 2.20 3,484 07:44:42
Bid Price Offer Price High Price Low Price Open Price
2.00 2.40 2.20 2.20 2.20
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Surgical,med Instr,apparatus 11.34 0.26 - - 20.52
Last Trade Time Trade Type Trade Size Trade Price Currency
14:23:20 O 3,484 2.00 GBX

Surgical Innovations (SUN) Latest News

Surgical Innovations (SUN) Discussions and Chat

Surgical Innovations (SUN) Most Recent Trades

Trade Time Trade Price Trade Size Trade Value Trade Type

Surgical Innovations (SUN) Top Chat Posts

Top Posts
Posted at 25/5/2023 07:31 by buywell3
No trades buywell can see over the last few days published reflect this ??

Todays RNS

Surgical Innovations Group plc (AIM: SUN), the designer, manufacturer and distributor of innovative medical technology for minimally invasive surgery ("MIS"), was notified on 24 May 2023 that, on 24 May 2023, Janis Glenn (wife of Jonathan Glenn, Non-executive Director) purchased 1,315,482 ordinary shares of 1p each in Surgical Innovations ("Ordinary Shares") at a price of 2.28 pence per share.

Surgical Innovations Group PLC

22 May 2023

Surgical Innovations Group Plc

Directorate changes and board succession planning

Surgical Innovations Group Plc (AIM: SUN), the designer, manufacturer and distributor of innovative technology for minimally invasive surgery, announces the appointment of Jonathan Glenn as Senior Independent Non-executive Director and Chairman-designate of the Company with immediate effect.

Jonathan is an experienced board director and chairman, with an excellent track record in the medical device sector. He is currently Non-executive Chairman of Tissue Regenix plc, and was formerly Group CEO of Consort Medical Plc from 2007 to 2020, where he oversaw the £230m acquisition of a European contract development and manufacturing organisation. Jonathan led the business as CEO until its acquisition for £505m in 2020. Jonathan is a member of the Institute of Chartered Accountants in England and Wales.

He joins the board in anticipation of the upcoming retirement of Professor Mike McMahon, the founder of the Company, who retires from the board at the Annual General Meeting of the Company expected to take place on 27 June 2023.

Following an orderly handover process, Jonathan will succeed Nigel Rogers as Chairman upon announcement of the interim results expected in September 2023. Nigel has indicated his intention to remain on the board until an additional independent non-executive director has been appointed.

Chairman of the Company, Nigel Rogers, commented: "It has been my great pleasure to lead the board since my appointment in 2015, and especially to work alongside Prof. Mike McMahon. As part of our planned succession arrangements, we are now delighted to have Jonathan joining us, and look forward to working with him to complete the transition in board composition for the next stage in the Company's evolution."

Past Trades

May 23, 2023 1.95p 1.81p 1.81p 1.95p 756
May 22, 2023 1.95p 2.05p 2.05p 1.95p 100,000
May 18, 2023 1.95p 1.86p 1.86p 1.95p 382
May 17, 2023 1.95p 2.05p 1.86p 1.95p 49,683
May 16, 2023 1.95p 2.05p 1.86p 1.95p 116,476
May 15, 2023 1.95p 1.86p 1.86p 1.95p 34,500
May 12, 2023 1.95p 2.07p 1.86p 1.95p 210,867
May 11, 2023 1.95p 1.86p 1.86p 1.95p 3,000
May 10, 2023 1.95p 2.07p 1.80p 1.95p 398,351
May 9, 2023 1.95p 2.07p 1.85p 1.95p 17,380
May 5, 2023 1.95p 2.05p 2.05p 1.95p 376,594
May 4, 2023 1.95p 2.05p 2.05p 1.95p 1,267
May 2, 2023 1.95p 2.05p 2.05p 1.95p 4,878
Apr 27, 2023 1.95p 2.05p 1.84p 1.95p 157,461
Apr 26, 2023 1.95p 2.05p 1.84p 1.95p 270,249
Apr 25, 2023 1.95p 1.84p 1.84p 1.95p 51,178
Apr 24, 2023 1.95p 1.84p 1.84p 1.95p 20,000
Apr 21, 2023 1.95p 1.96p 1.82p 1.95p 572,078
Apr 20, 2023 1.95p 1.96p 1.81p 1.95p 191,274
Apr 19, 2023 1.95p 1.96p 1.83p 1.95p 256,282
Apr 18, 2023 1.95p 1.96p 1.87p 1.95p 11,490
Apr 17, 2023 1.95p 1.87p 1.87p 1.95p 125,000
Apr 14, 2023 1.95p 1.97p 1.85p 1.95p 550,000
Apr 12, 2023 1.95p 1.97p 1.97p 1.95p 100,508
Apr 11, 2023 1.95p 1.97p 1.83p 1.95p 82,107
Apr 6, 2023 1.95p 1.97p 1.97p 1.95p 101,221
Apr 4, 2023 1.95p 1.98p 1.98p 1.95p 407
Apr 3, 2023 1.95p 1.98p 1.83p 1.95p 177,465
Mar 31, 2023 1.95p 2.10p 1.80p 1.95p 12,240
Mar 30, 2023 2.10p 2.09p 1.81p 1.95p 1,747,493
Mar 29, 2023 1.95p 2.03p 1.99p 2.05p 549,353
Mar 28, 2023 1.90p 1.99p 1.83p 1.90p 265,245
Mar 27, 2023 1.90p 1.99p 1.83p 1.90p 141,710
Mar 24, 2023 1.90p 1.83p 1.83p 1.90p 73,049
Mar 23, 2023 1.90p 1.99p 1.99p 1.90p 13,467
Mar 22, 2023 1.90p 1.99p 1.83p 1.90p 54,495
Mar 21, 2023 1.90p 1.83p 1.83p 1.90p 83,671
Mar 20, 2023 1.95p 1.99p 1.82p 1.90p 242,833
Mar 17, 2023 1.95p 1.99p 1.90p 1.95p 84,116
Mar 16, 2023 1.95p 1.99p 1.90p 1.95p 51,424
Mar 15, 2023 2.05p 2.05p 1.90p 1.95p 140,000
Mar 14, 2023 2.05p 2.08p 1.91p 2.05p 8,957
Mar 13, 2023 2.05p 2.08p 1.90p 2.05p 36,220
Mar 10, 2023 2.05p 1.92p 1.92p 2.05p 70,000
Mar 9, 2023 2.05p 1.92p 1.92p 2.05p 18,897
Mar 8, 2023 2.05p 2.15p 1.92p 2.05p 6,975
Mar 7, 2023 2.05p 2.15p 1.90p 2.05p 53,746
Mar 6, 2023 2.15p 2.21p 2.00p 2.05p 123,158
Mar 3, 2023 2.15p 2.27p 2.00p 2.15p 679,024
Mar 2, 2023 2.05p 2.29p 2.00p 2.15p 534,776

Posted at 30/3/2023 22:33 by buywell3
This is a must listen to video presentation of the Final results IMO


It is buywells understanding that Singer Capital have a EBITDA forecast for SUN at 0.9 Million pounds for 2023


buywell opines that due to the pent up demand in the US and Japan for 5mm Elite trocars and optical trocars --- plus new orders from India/Germany/other countries due to new market penetration by way of gaining entry to new hospital sales of SI devices on the back of CMR Surgical sales which of course include the 5mm Elite trocar and the optical trocar plus consumables = Add on sales of other existing SI instrumentation and EH offerings plus consumables for both ongoing

Due to this buywell is forecasting more than 1M profit for 2023

Double that for 2024 as EU, US and APAC market penetration increases with MDR completed and the new Logi range of graspers and cutters gets added = 2024 profit 2.5 Million pounds

Then we have the AMS expected sales of LiquibandFix8 in the USA --- starting soon

This alone could be transformational if PMA is given by the US later this financial year

Assuming a profit of 1M the P/E for SUN would be 19.12 at todays Mkt Cap

At a 2024 2.5M profit the SUN forward P/E would be 7.6


Posted at 29/3/2023 22:36 by buywell3
Look at this Final results presentation slides just made available


Sales look set to accelerate from here into the rest of 2023

Market Environment – USA

• YelloPort™ Elite 5mm and Optical trocar
expected to have strong impact on US sales this
• Momentum now growing with some early
account conversions

Market Environment – UK

• New account conversions underpinned by
sustainability driving growth
• Investment in key Sales & Marketing
positions enhancing relationships in NHSSC*
and private sector
• Growth continues into Q1 with sales YTD up
on 2022

Market Environment – EU

• Strong return to growth, +28%
• Sustainability resonates in
some key market
• Sales & Marketing training has
renewed partner focus
• New Distributor in Germany
beginning to gain traction

Market Environment – APAC

• Continued growth up 24.6%
• Japan underpins sales in the
region and registration for
5mm Optical in Q4 will provide
further opportunity
• India will have positive impact
on 2023

Market Environment – ROW

• New distribution partner for

Market Environment – OEM Business

• Strong sales growth up 45%
• Collaboration with CMR to develop YP
Elite opens opportunity within
robotics and new territories
• Ongoing supply chain issues disrupted
sales to partners in Q1
• Strong order book for Q2

buywell notes --- this has nearly tripled since 2020 and looks set to grow further this year

2023 NPD Projects (under MDR):

• Cost down initiatives on YelloPort Elite®
• Extension to Logi® Resposable® range,
three new jaw configurations

buywell note

The extension to the Logi range above is expected to commence Q4 2023

At present it is just one cutter

buywell expects various grasper types to be added to the range

As buywell has posted 2024 looks set to be a bumper year if AMS LiquibandFix8 is added to the mix with PMA approval for sales to commence in the US --- could be as early at august 2023 --- sales of CMR Surgical Versius robots continues to gain traction = very good for Surgical Innovations Elite 5mm sales + consumables ongoing


Posted at 06/3/2023 09:54 by gnnmartin
Curious, I got an email from the Investigate Alert service this morning telling me that SUN had announced their half year profits. It did not (of course) lead me to an announcement, rather to a suggestion of an announcement that I was not privileged to see.
Posted at 28/2/2023 14:18 by z1co
H2 revenue was really strong and was 10% more than H1.This strong momentum is likely to continue in the current year.

The company will provide more info at the time of it's full year results.

Share price is still rather subdued but will rebound as the year progresses.

Posted at 28/2/2023 13:27 by barrenwuffet2
It’s two years post Covid now. SUN should be showing double digit growth alongside all other medical companies
Posted at 28/2/2023 13:09 by z1co
It looks like MM's are a bit short on the stock just 0.5m of buys and they have increased the share price by 6%.

With the full year results in a few weeks the shares are likely to rise a lot more.

Posted at 06/7/2022 08:59 by barrenwuffet2
It looks to me like the company is stuck in a no-mans land, on the one hand, not big enough to develop new products and at the mercy of the NHS and it’s lack of resource and on the other, too expensive to represent good value for an acquirer. This share has not really delivered shareholder value for years and there is nothing in the latest announcement that makes we think that this will change. I’d like to hear Buywells view on the medium term future for SUN after all of his puffing-up.
Posted at 15/6/2022 06:55 by barrenwuffet2
It looks like the clouds have covered The SUN. A perennial underachiever whatever Buywell says. The NHS is in a big mess.
Posted at 31/12/2019 11:18 by van zandt
May I say the same to most.
I feel such excitement coming on!!
No. Nothing to do with SUN share price.
as ever regards

Surgical Innovations share price data is direct from the London Stock Exchange
Your Recent History
Surgical I..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to ADVFN
Register Now

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

Support: +44 (0) 203 8794 460 |

V: D: 20230607 17:06:25